Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant Investment Progress Announcement

30 Apr 2014 17:03

RNS Number : 9752F
J.P. Morgan Private Equity Ltd
30 April 2014
 

 

SIGNIFICANT INVESTMENT PROGRESS TO DATE

· Invested approximatley $50 million in 4 Companies Since December

· Represents ONE-THIRD OF $150 MILLION of the year-end 2015 Target investment amount

 

GUERNSEY, 30 APRIL 2014

 

In January 2014 JPEL announced that it would seek to invest $150 million through December 2015 in secondary direct deals or concentrated private equity LP positions.

 

JPEL is pleased to announce that with the completion of its fourth investment, it has deployed approximately $50 million of its $150 million investment target. Due to strong distribution flows, JPEL has been able to fund all investments without increasing borrowings under its flexible credit facility.

 

The four investments include:

· In December, JPEL invested approximately $14 million in a US-based tax advisory services firm whose primary business is to provide high-value consulting services relating to government-sponsored tax incentives.

· In February, JPEL invested approximately $14 million in Datamars SA, a leading supplier of animal identification systems (including pet and livestock) and textile identification systems.

· Also in February, JPEL invested approximately $7 million in Placid Holdings, a holding company with an investment in a leading branded Asian handset distributor, with a leading market position in smart phones and feature phones in India.

· In April, JPEL participated in a syndicate of global investors led by Arle Capital to acquire Innovia Group from the Candover 2001 Fund. JPEL invested approximately $14 million in Innovia, an international manufacturer of high quality, speciality films for its key markets of labels, overwrap, packaging and polymer banknote substrate.

 

Each of the four investments share common attributes that JPEL seeks:

· Attractive entry value: On aggregated basis, entry value for the four companies was approximately 6.7x LTM EBITDA and 5.6x 2014P EBITDA

· Manageable leverage: On a weighted average basis, debt at time of investment was approximately 1.8x 2013 LTM EBITDA. 2 of the 4 companies have net cash positions

· High margins: Weighted average LTM EBITDA margins of approximately 25%

· Market leadership: Each of the four companies is a market leader (top 1-3 player) in their respective business segments

· Potential shorter duration: All four companies are existing, mature private equity investments with the potential to be exited in the next 2 to 4 years

· Visible EBITDA growth: Each company projects significant EBITDA growth in the near or mid-term

 

JPEL currently has a very strong investment pipeline and is engaged in due diligence on two potential transactions that could be completed over the next two to three months. Should these investments close, JPEL will have deployed approximately half of its $150 million investment target.

 

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Greg Getschow

+1 212 648 1150

Gregory.Getschow@jpmorgan.com

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPZZ, JPSZ). The Company's capital structure consists of three classes of shares: US$ Equity Shares and two classes of Zero Dividend Preference Shares due 2015 and 2017, respectively.

 

On 15 January 2014, JPEL announced a strategic update, which included plans to maximize net asset value through greater emphasis on JPEL's existing post-credit crisis investment strategy. As part of this update, JPEL announced that it would cease dividend and capital distributions to US$ Equity Shareholders and continue its post-credit crisis investment strategy and will seek to invest $150 million in secondary direct deals or concentrated private equity LP positions. The Company's goal is to create concentrated portfolio to improve ability to assess risk and to increase transparency on underlying portfolio. At the end of the investment period in December 2015, JPEL expects that its top 30 company positions will comprise the majority of its total net asset value.

 

The Company also announced a proposal for the creation of Redeemable Realisation Share Class ("RRS") whereby US$ Equity shareholders would be offered the option to transfer their US$ Equity shares for RRS Shares which will entitle holders to all cash realisations from the Company's investment portfolio in proportion to their aggregate holding within the equity of the Company. This proposal requires shareholder approval and would take effect in 24 months, after the 2015 ZDP Shares are retired.

 

On 15 January 2014, institutional investors purchased 84 million US$ Equity Shares through market purchases at $0.80 per share, an 8.3% premium to the 14 January 2014 share price.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURRNRSOASOAR
Date   Source Headline
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.